ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 693.4 | 650.3 | 611.8 |
| Other income | 13.8 | 15.1 | 8.2 |
| Total income | 707.2 | 665.4 | 620.0 |
| Profit before exceptional items & tax | 25.0 | 33.2 | 11.9 |
| Exceptional items | 0.0 | -31.9 | 0.0 |
| Profit before tax | 25.0 | 1.2 | 11.9 |
| Net profit | 16.5 | 4.0 | 6.0 |
| Operating margin | 3.5% | 0.2% | 1.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +175.00% |
|---|---|
| Net profit, quarter on quarter | +312.50% |
| Revenue, year on year | +13.30% |
| Operating profit, year on year | +202.70% |
| Operating profit, quarter on quarter | -38.10% |
BSE results filing, NSE: HCG. Figures extracted from the filing.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹568.85
- Market cap
- ₹8,493 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 751.6×Sector 54.5×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Earnings Call Transcript: Key Takeaways
Q2 revenue ₹732 Cr, +16% YoY; H1 ₹1,410 Cr, +15%. EBITDA margin 19.7% despite ~₹6 Cr wage-revision hit. Trade-margin cap guided at mid-to-high single-digit annualised impact, with few specifics.
Healthcare Global Enterprises Results Update
HCG reported Q2 FY27 revenue of INR 7,318 Mn, up 16% YoY, with adjusted EBITDA up 17%. Results cover the quarter and half-year ended September 30, 2026.
Healthcare Global Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 7,318 Mn (+16% YoY) and Adjusted EBITDA INR 1,425 Mn (+17%, 19.7% margin). Reported PAT INR 92.5 Mn. Plan to add 1,000 beds by FY30.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Healthcare Global Enterprises Q2 FY27 Results: Net Profit ₹9.2 Cr, Down 55.6% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹731.8 Cr (+13.1% YoY) and net profit of ₹9.2 Cr (-55.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.2 Cr · -55.6% YoY
Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.